Our Products

Rotary Evaporator

Laboratory equipment

Jacketed Reactor

Contact Us

We Cherish All Interactions

Verification of I-131Yields from the neutron irradiation .

Verification of I-131Yields from the neutron irradiation .

Sep 01, 2019 · The production of I-131 for use in medicine can be accomplished by the neutron irradiation of tellurium, typically in the form of TeO 2. Numerous isotope producing reactors around the world use this technique for I-131 production. However, for many years there has been no production of radiopharmaceutical I-131 in the U.S.

131I-Nimotuzumab – A potential radioimmunotherapeutic .

131I-Nimotuzumab – A potential radioimmunotherapeutic .

Aug 01, 2015 · 131 I was produced in-house by (n, γ) activation of tellurium oxide target and extracted by dry distillation technique (Ambade et al., 2015). The product was available as sodium iodide (Na 131 I), pH 8–10. DMEM, HEPES and sodium bicarbonate were obtained from Sigma, USA while fetal bovine serum (FBS) was procured from GIBCO Laboratories, USA.

The role of clinicians in determining radioactive iodine .

The role of clinicians in determining radioactive iodine .

BACKGROUND: There is controversy regarding the optimal management of thyroid cancer. The proportion of patients with low‐risk thyroid cancer who received radioactive iodine (RAI) treatment increased over the last 20 years, and little is known about the role played by clinicians in hospital‐level RAI use for low‐risk disease.

Radiopharmacy

Radiopharmacy

TeO 2 (5-20 g) was irradiated for one week in Dhruva reactor at a neutron flux of 8.3 × 10 13 n 1 cm-2 s-1 and was mixed with inactive TeO 2 powder with a view to simulate full production batch of 50 Ci. The simulated target in a quartz crucible is loaded into a specially designed quartz assembly -with the provision to purge gas- in an .

WO1998059347A1 - Neutron-driven element transmuter .

WO1998059347A1 - Neutron-driven element transmuter .

A material is exposed to a neutron flux by distributing it in a neutron-diffusing medium surrounding a neutron source. The diffusing medium is transparent to neutrons and so arranged that neutron scattering substantially enhances the neutron flux to which the material is exposed. Such enhanced neutron exposure may be used to produce useful radio-isotopes, in particular for medical applications .

From the Desk of Chief Executive

From the Desk of Chief Executive

Board of Radiation & Isotope Technology (BRIT), the unit of DAE, is focussed on bringing the benefits of the use of radioisotope applications and radiation technology across industry, healthcare, research and agricultural sectors of the society. Harnessing the spin-offs from the

Radioimmunoimaging with longer-lived positron-emitting .

Radioimmunoimaging with longer-lived positron-emitting .

May 20, 2009 · Production of 124 I. 124 I can be produced using a conventional medical cyclotron using the 124 Te(p,n) 124 I and 124 Te(d,2n) 124 I reactions [Table 2].Typically, highly enriched tellurium dioxide is used as the target and 124 I is isolated using dry distillation with minimal impurities (24–26).The yield (<0.1mCi/μAh) from the 124 Te(p,n) 124 I reaction is low at 15 MeV ().

Reactor-Produced Therapeutic Radionuclides | SpringerLink

Reactor-Produced Therapeutic Radionuclides | SpringerLink

Ambade RN, Shinde SN, Khan MSA, et al. Development of a dry distillation technology for the production of 131 I using medium flux reactor for radiopharmaceutical applications. J Radioanal Nucl Chem. 2015;303:451–67. CrossRef Google Scholar

5th INTERNATIONAL CONFERENCE ON ISOTOPES

5th INTERNATIONAL CONFERENCE ON ISOTOPES

Results of the research have demonstrated that parameters of generators after their long-term exploitation were kept on the level, allowing their clinical use. 26 Production of radioisotopes in the BR2 high-flux reactor B. Ponsard SCK.CEN, BR2 Reactor, Mol, Belgium The BR2 reactor, put into operation in 1963 and refurbished in 1995-1997, is a .

Production and Clinical Applications of .

Production and Clinical Applications of .

Jul 01, 2016 · Owing to the suitable decay characteristics (t 1/2 = 6.73 days, E β max = 497 keV, Eγ = 112 keV [6.4%], 208 keV [11%]) as well as the feasibility of large-scale production in adequate specific activity and radionuclide purity by using a moderate flux reactor, 177 Lu deemed a promising radionuclide in the development of 177 Lu-EDTMP complex.

Development of a dry distillation technology for the .

Development of a dry distillation technology for the .

Development of a dry distillation technology for the production of 131I using medium flux reactor for radiopharmaceutical applications R. N. Ambade • S. N. Shinde • M. S. A. Khan • S. P .

Abstracts - Scientific Session 1: Thyroid Diseases I

Abstracts - Scientific Session 1: Thyroid Diseases I

Erbium-169 with a low beta energy place not a role, the energy was absorbed by the syringe wall. Using rhenium-186 a 2.5 mm Perspex radiation protection of the syringe is sufficient. However, for using yttrium-90 with a maximum beta-energy of 2.1 MeV a 5 mm Perspex wall and a manipulator for fixation of the needle during the therapy is necessary.

Man Made Isotopes - PDF Free Download

Man Made Isotopes - PDF Free Download

Standardization of Dry-distillation Technique for the Recovery of Radioiodine from Irradiated Tellurium Matrix Alpha spectrum of radiochemically separated Pu-236 In view of important therapeutic and diagnostic applications of different isotopes of radioiodine such as V. K . M a n c h a n d a v k m @ b a r c . g o vv.. i n n> (131, 120, 123, 124 .

The role of clinicians in determining radioactive iodine .

The role of clinicians in determining radioactive iodine .

BACKGROUND: There is controversy regarding the optimal management of thyroid cancer. The proportion of patients with low‐risk thyroid cancer who received radioactive iodine (RAI) treatment increased over the last 20 years, and little is known about the role played by clinicians in hospital‐level RAI use for low‐risk disease.

JoVE | Peer Reviewed Scientific Video Journal - Methods .

JoVE | Peer Reviewed Scientific Video Journal - Methods .

JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles.

Abstracts - Scientific Poster Session 1: Thyroid

Abstracts - Scientific Poster Session 1: Thyroid

Results: Production feasibility studies showed that at a fast flux neutron density of 7.5 × 1013 cm2s-1 and an irradiation time of 120 h, using enriched 106Cd target 340 MBq of no-carrier-added 103 Pd per batch can be produced. The method is thus suitable for medium-scale production of .

Production and Clinical Applications of .

Production and Clinical Applications of .

Jul 01, 2016 · Owing to the suitable decay characteristics (t 1/2 = 6.73 days, E β max = 497 keV, Eγ = 112 keV [6.4%], 208 keV [11%]) as well as the feasibility of large-scale production in adequate specific activity and radionuclide purity by using a moderate flux reactor, 177 Lu deemed a promising radionuclide in the development of 177 Lu-EDTMP complex.

CA2294063C - Neutron-driven element transmuter - Google .

CA2294063C - Neutron-driven element transmuter - Google .

A material is exposed to a neutron flux by distributing it in a neutron- diffusing medium surrounding a neutron source. The diffusing medium is transparent to neutrons and so arranged that neutron scattering substantially enhances the neutron flux to which the material is exposed. Such enhanced neutron exposure may be used to produce useful rad io- isotopes, in particular for medical .

EP0990238A1 - Neutron-driven element transmuter - Google .

EP0990238A1 - Neutron-driven element transmuter - Google .

A material is exposed to a neutron flux by distributing it in a neutron-diffusing medium surrounding a neutron source. The diffusing medium is transparent to neutrons and so arranged that neutron scattering substantially enhances the neutron flux to which the material is exposed. Such enhanced neutron exposure may be used to produce useful radio-isotopes, in particular for medical applications .

Mechanochemically synthesized mesoporous alumina: An .

Mechanochemically synthesized mesoporous alumina: An .

Feb 08, 2020 · Iodine-131 was produced by irradiation of natural TeO 2 target in the Dhruva reactor via 130 Te (n,γ) 131 Te → β − 131 I nuclear reaction and was radiochemically separated from the irradiated target by dry distillation process to obtain 131 I[NaI] solution as reported by us earlier . Mesoporous alumina was synthesized by solid state .

CA2294063C - Neutron-driven element transmuter - Google .

CA2294063C - Neutron-driven element transmuter - Google .

A material is exposed to a neutron flux by distributing it in a neutron- diffusing medium surrounding a neutron source. The diffusing medium is transparent to neutrons and so arranged that neutron scattering substantially enhances the neutron flux to which the material is exposed. Such enhanced neutron exposure may be used to produce useful rad io- isotopes, in particular for medical .

Pillai MRA | Ph.D; D.Sc | Group Director | Molecular .

Pillai MRA | Ph.D; D.Sc | Group Director | Molecular .

Development of a dry distillation technology for the production of 131I using medium flux reactor for radiopharmaceutical applications Article Full-text available

Appendix-2 Country Report on Isotope Production and Its .

Appendix-2 Country Report on Isotope Production and Its .

The RSG-GAS reactor-BATAN, is designed as a multipurpose reactor with a nominal power of 30 MW, producing thermal neutron flux in the order within 2.0x10 14 n.cm-2.s-1. As a multipurpose reactor, RSG-GAS provides facilities for utilization on material testing, radioisotope production, R&D using neutron irradiation as well as training.

Journal of Radioanalytical and Nuclear Chemistry (v.303 .

Journal of Radioanalytical and Nuclear Chemistry (v.303 .

177 Lu-maltolate (177 Lu-MAL) was successfully developed which can be widely used in bone palliation therapy. At optimized conditions a radiochemical purity of about >99 % was obtained for 177 Lu-MAL shown by ITLC (specific activity, 970–1,000 MBq/mmole). Biodistribution studies of 177 177

Medical radioisotopes production without a nuclear reactor .

Medical radioisotopes production without a nuclear reactor .

This chapter discusses the production of reactor-based The most commonly used reactor produced isotopes in medical applications are technetium-99m (99mTc) [decay product of the fission product .

(PDF) Development of a dry distillation technology for the .

(PDF) Development of a dry distillation technology for the .

The present article describes the development of an indigenous technology for large scale production of 131I based on the neutron irradiation of TeO2 target followed by the separation of 131I using.

Development of a dry distillation technology for the .

Development of a dry distillation technology for the .

Aug 31, 2014 · The present article describes the development of an indigenous technology for large scale production of 131 I based on the neutron irradiation of TeO 2 target followed by the separation of 131 I using dry distillation technique.

Swamirao Namdeo Shinde's research works | Bhabha Atomic .

Swamirao Namdeo Shinde's research works | Bhabha Atomic .

The present article describes the development of an indigenous technology for large scale production of 131I based on the neutron irradiation of TeO2 target followed by the separation of 131I using.

Preparation and preclinical evaluation of 131I‐trastuzumab .

Preparation and preclinical evaluation of 131I‐trastuzumab .

Jan 01, 2017 · Ambade RN, Shinde SN, Khan MSA, et al. Development of a dry distillation tech- in patients with breast cancer. It is envisaged that self‐reliance 131 nology for the production of 131I using medium flux reactor for through indigenous availability and clinical utilization of I‐ radiopharmaceutical applications.

Continuous Process Dynamics, Stability, Control and .

Continuous Process Dynamics, Stability, Control and .

You can write a book review and share your experiences. Other readers will always be interested in your opinion of the books you've read. Whether you've loved the book or not, if you give your honest and detailed thoughts then people will find new books that are right for them.